Roche and Genentech warn of counterfeit Avastin

02/14/2012 | Reuters · Wall Street Journal, The

Roche Holding and its unit Genentech reported that a fake version of their injectable cancer drug Avastin was found in the U.S. The FDA is investigating and has alerted medical practices about the counterfeit product.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA